Global and China Pulmonary Arterial Hypertension (PAH) Medicine Market Insights, Forecast to 2026

Global and China Pulmonary Arterial Hypertension (PAH) Medicine Market Insights, Forecast to 2026

Table of Contents
1 Study Coverage
1.1 Pulmonary Arterial Hypertension (PAH) Medicine Product Introduction
1.2 Market Segments
1.3 Key Pulmonary Arterial Hypertension (PAH) Medicine Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Pulmonary Arterial Hypertension (PAH) Medicine Market Size Growth Rate by Type
1.4.2 Calcium Channel Blockers
1.4.3 Novel Targeted Drugs
1.4.4 Other
1.5 Market by Application
1.5.1 Global Pulmonary Arterial Hypertension (PAH) Medicine Market Size Growth Rate by Application
1.5.2 Secondary Pulmonary Hypertension (SPH)
1.5.3 Primary Pulmonary Hypertension (PPH)
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Pulmonary Arterial Hypertension (PAH) Medicine Market Size, Estimates and Forecasts
2.1.1 Global Pulmonary Arterial Hypertension (PAH) Medicine Revenue 2015-2026
2.1.2 Global Pulmonary Arterial Hypertension (PAH) Medicine Sales 2015-2026
2.2 Global Pulmonary Arterial Hypertension (PAH) Medicine, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.3 Pulmonary Arterial Hypertension (PAH) Medicine Historical Market Size by Region (2015-2020)
2.3.1 Global Pulmonary Arterial Hypertension (PAH) Medicine Retrospective Market Scenario in Sales by Region: 2015-2020
2.3.2 Global Pulmonary Arterial Hypertension (PAH) Medicine Retrospective Market Scenario in Revenue by Region: 2015-2020
2.4 Pulmonary Arterial Hypertension (PAH) Medicine Market Estimates and Projections by Region (2021-2026)
2.4.1 Global Pulmonary Arterial Hypertension (PAH) Medicine Sales Forecast by Region (2021-2026)
2.4.2 Global Pulmonary Arterial Hypertension (PAH) Medicine Revenue Forecast by Region (2021-2026)
3 Global Pulmonary Arterial Hypertension (PAH) Medicine Competitor Landscape by Players
3.1 Global Top Pulmonary Arterial Hypertension (PAH) Medicine Sales by Manufacturers
3.1.1 Global Pulmonary Arterial Hypertension (PAH) Medicine Sales by Manufacturers (2015-2020)
3.1.2 Global Pulmonary Arterial Hypertension (PAH) Medicine Sales Market Share by Manufacturers (2015-2020)
3.2 Global Pulmonary Arterial Hypertension (PAH) Medicine Manufacturers by Revenue
3.2.1 Global Pulmonary Arterial Hypertension (PAH) Medicine Revenue by Manufacturers (2015-2020)
3.2.2 Global Pulmonary Arterial Hypertension (PAH) Medicine Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Pulmonary Arterial Hypertension (PAH) Medicine Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Pulmonary Arterial Hypertension (PAH) Medicine Revenue in 2019
3.2.5 Global Pulmonary Arterial Hypertension (PAH) Medicine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Global Pulmonary Arterial Hypertension (PAH) Medicine Price by Manufacturers
3.4 Global Pulmonary Arterial Hypertension (PAH) Medicine Manufacturing Base Distribution, Product Types
3.4.1 Pulmonary Arterial Hypertension (PAH) Medicine Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Pulmonary Arterial Hypertension (PAH) Medicine Product Type
3.4.3 Date of International Manufacturers Enter into Pulmonary Arterial Hypertension (PAH) Medicine Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Pulmonary Arterial Hypertension (PAH) Medicine Market Size by Type (2015-2020)
4.1.1 Global Pulmonary Arterial Hypertension (PAH) Medicine Sales by Type (2015-2020)
4.1.2 Global Pulmonary Arterial Hypertension (PAH) Medicine Revenue by Type (2015-2020)
4.1.3 Pulmonary Arterial Hypertension (PAH) Medicine Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Pulmonary Arterial Hypertension (PAH) Medicine Market Size Forecast by Type (2021-2026)
4.2.1 Global Pulmonary Arterial Hypertension (PAH) Medicine Sales Forecast by Type (2021-2026)
4.2.2 Global Pulmonary Arterial Hypertension (PAH) Medicine Revenue Forecast by Type (2021-2026)
4.2.3 Pulmonary Arterial Hypertension (PAH) Medicine Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Pulmonary Arterial Hypertension (PAH) Medicine Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Pulmonary Arterial Hypertension (PAH) Medicine Market Size by Application (2015-2020)
5.1.1 Global Pulmonary Arterial Hypertension (PAH) Medicine Sales by Application (2015-2020)
5.1.2 Global Pulmonary Arterial Hypertension (PAH) Medicine Revenue by Application (2015-2020)
5.1.3 Pulmonary Arterial Hypertension (PAH) Medicine Price by Application (2015-2020)
5.2 Pulmonary Arterial Hypertension (PAH) Medicine Market Size Forecast by Application (2021-2026)
5.2.1 Global Pulmonary Arterial Hypertension (PAH) Medicine Sales Forecast by Application (2021-2026)
5.2.2 Global Pulmonary Arterial Hypertension (PAH) Medicine Revenue Forecast by Application (2021-2026)
5.2.3 Global Pulmonary Arterial Hypertension (PAH) Medicine Price Forecast by Application (2021-2026)
6 China by Players, Type and Application
6.1 China Pulmonary Arterial Hypertension (PAH) Medicine Market Size YoY Growth 2015-2026
6.1.1 China Pulmonary Arterial Hypertension (PAH) Medicine Sales YoY Growth 2015-2026
6.1.2 China Pulmonary Arterial Hypertension (PAH) Medicine Revenue YoY Growth 2015-2026
6.1.3 China Pulmonary Arterial Hypertension (PAH) Medicine Market Share in Global Market 2015-2026
6.2 China Pulmonary Arterial Hypertension (PAH) Medicine Market Size by Players (International and Local Players)
6.2.1 China Top Pulmonary Arterial Hypertension (PAH) Medicine Players by Sales (2015-2020)
6.2.2 China Top Pulmonary Arterial Hypertension (PAH) Medicine Players by Revenue (2015-2020)
6.3 China Pulmonary Arterial Hypertension (PAH) Medicine Historic Market Review by Type (2015-2020)
6.3.1 China Pulmonary Arterial Hypertension (PAH) Medicine Sales Market Share by Type (2015-2020)
6.3.2 China Pulmonary Arterial Hypertension (PAH) Medicine Revenue Market Share by Type (2015-2020)
6.3.3 China Pulmonary Arterial Hypertension (PAH) Medicine Price by Type (2015-2020)
6.4 China Pulmonary Arterial Hypertension (PAH) Medicine Market Estimates and Forecasts by Type (2021-2026)
6.4.1 China Pulmonary Arterial Hypertension (PAH) Medicine Sales Forecast by Type (2021-2026)
6.4.2 China Pulmonary Arterial Hypertension (PAH) Medicine Revenue Forecast by Type (2021-2026)
6.4.3 China Pulmonary Arterial Hypertension (PAH) Medicine Price Forecast by Type (2021-2026)
6.5 China Pulmonary Arterial Hypertension (PAH) Medicine Historic Market Review by Application (2015-2020)
6.5.1 China Pulmonary Arterial Hypertension (PAH) Medicine Sales Market Share by Application (2015-2020)
6.5.2 China Pulmonary Arterial Hypertension (PAH) Medicine Revenue Market Share by Application (2015-2020)
6.5.3 China Pulmonary Arterial Hypertension (PAH) Medicine Price by Application (2015-2020)
6.6 China Pulmonary Arterial Hypertension (PAH) Medicine Market Estimates and Forecasts by Application (2021-2026)
6.6.1 China Pulmonary Arterial Hypertension (PAH) Medicine Sales Forecast by Application (2021-2026)
6.6.2 China Pulmonary Arterial Hypertension (PAH) Medicine Revenue Forecast by Application (2021-2026)
6.6.3 China Pulmonary Arterial Hypertension (PAH) Medicine Price Forecast by Application (2021-2026)
7 North America
7.1 North America Pulmonary Arterial Hypertension (PAH) Medicine Market Size YoY Growth 2015-2026
7.2 North America Pulmonary Arterial Hypertension (PAH) Medicine Market Facts & Figures by Country
7.2.1 North America Pulmonary Arterial Hypertension (PAH) Medicine Sales by Country (2015-2020)
7.2.2 North America Pulmonary Arterial Hypertension (PAH) Medicine Revenue by Country (2015-2020)
7.2.3 U.S.
7.2.4 Canada
8 Europe
8.1 Europe Pulmonary Arterial Hypertension (PAH) Medicine Market Size YoY Growth 2015-2026
8.2 Europe Pulmonary Arterial Hypertension (PAH) Medicine Market Facts & Figures by Country
8.2.1 Europe Pulmonary Arterial Hypertension (PAH) Medicine Sales by Country
8.2.2 Europe Pulmonary Arterial Hypertension (PAH) Medicine Revenue by Country
8.2.3 Germany
8.2.4 France
8.2.5 U.K.
8.2.6 Italy
8.2.7 Russia
9 Asia Pacific
9.1 Asia Pacific Pulmonary Arterial Hypertension (PAH) Medicine Market Size YoY Growth 2015-2026
9.2 Asia Pacific Pulmonary Arterial Hypertension (PAH) Medicine Market Facts & Figures by Country
9.2.1 Asia Pacific Pulmonary Arterial Hypertension (PAH) Medicine Sales by Region (2015-2020)
9.2.2 Asia Pacific Pulmonary Arterial Hypertension (PAH) Medicine Revenue by Region
9.2.3 China
9.2.4 Japan
9.2.5 South Korea
9.2.6 India
9.2.7 Australia
9.2.8 Taiwan
9.2.9 Indonesia
9.2.10 Thailand
9.2.11 Malaysia
9.2.12 Philippines
9.2.13 Vietnam
10 Latin America
10.1 Latin America Pulmonary Arterial Hypertension (PAH) Medicine Market Size YoY Growth 2015-2026
10.2 Latin America Pulmonary Arterial Hypertension (PAH) Medicine Market Facts & Figures by Country
10.2.1 Latin America Pulmonary Arterial Hypertension (PAH) Medicine Sales by Country
10.2.2 Latin America Pulmonary Arterial Hypertension (PAH) Medicine Revenue by Country
10.2.3 Mexico
10.2.4 Brazil
10.2.5 Argentina
11 Middle East and Africa
11.1 Middle East and Africa Pulmonary Arterial Hypertension (PAH) Medicine Market Size YoY Growth 2015-2026
11.2 Middle East and Africa Pulmonary Arterial Hypertension (PAH) Medicine Market Facts & Figures by Country
11.2.1 Middle East and Africa Pulmonary Arterial Hypertension (PAH) Medicine Sales by Country
11.2.2 Middle East and Africa Pulmonary Arterial Hypertension (PAH) Medicine Revenue by Country
11.2.3 Turkey
11.2.4 Saudi Arabia
11.2.5 U.A.E
12 Company Profiles
12.1 Pfizer
12.1.1 Pfizer Corporation Information
12.1.2 Pfizer Description and Business Overview
12.1.3 Pfizer Sales, Revenue and Gross Margin (2015-2020)
12.1.4 Pfizer Pulmonary Arterial Hypertension (PAH) Medicine Products Offered
12.1.5 Pfizer Recent Development
12.2 Gilead Sciences
12.2.1 Gilead Sciences Corporation Information
12.2.2 Gilead Sciences Description and Business Overview
12.2.3 Gilead Sciences Sales, Revenue and Gross Margin (2015-2020)
12.2.4 Gilead Sciences Pulmonary Arterial Hypertension (PAH) Medicine Products Offered
12.2.5 Gilead Sciences Recent Development
12.3 Eli Lilly
12.3.1 Eli Lilly Corporation Information
12.3.2 Eli Lilly Description and Business Overview
12.3.3 Eli Lilly Sales, Revenue and Gross Margin (2015-2020)
12.3.4 Eli Lilly Pulmonary Arterial Hypertension (PAH) Medicine Products Offered
12.3.5 Eli Lilly Recent Development
12.4 Actelion Pharmaceuticals
12.4.1 Actelion Pharmaceuticals Corporation Information
12.4.2 Actelion Pharmaceuticals Description and Business Overview
12.4.3 Actelion Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
12.4.4 Actelion Pharmaceuticals Pulmonary Arterial Hypertension (PAH) Medicine Products Offered
12.4.5 Actelion Pharmaceuticals Recent Development
12.5 United Therapeutics Corporation
12.5.1 United Therapeutics Corporation Corporation Information
12.5.2 United Therapeutics Corporation Description and Business Overview
12.5.3 United Therapeutics Corporation Sales, Revenue and Gross Margin (2015-2020)
12.5.4 United Therapeutics Corporation Pulmonary Arterial Hypertension (PAH) Medicine Products Offered
12.5.5 United Therapeutics Corporation Recent Development
12.11 Pfizer
12.11.1 Pfizer Corporation Information
12.11.2 Pfizer Description and Business Overview
12.11.3 Pfizer Sales, Revenue and Gross Margin (2015-2020)
12.11.4 Pfizer Pulmonary Arterial Hypertension (PAH) Medicine Products Offered
12.11.5 Pfizer Recent Development
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter's Five Forces Analysis
13.5 Primary Interviews with Key Pulmonary Arterial Hypertension (PAH) Medicine Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Pulmonary Arterial Hypertension (PAH) Medicine Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
List of Tables
Table 1. Pulmonary Arterial Hypertension (PAH) Medicine Market Segments
Table 2. Ranking of Global Top Pulmonary Arterial Hypertension (PAH) Medicine Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Pulmonary Arterial Hypertension (PAH) Medicine Market Size Growth Rate by Type 2020-2026 (K Units) & (US$ Million)
Table 4. Major Manufacturers of Calcium Channel Blockers
Table 5. Major Manufacturers of Novel Targeted Drugs
Table 6. Major Manufacturers of Other
Table 7. Global Pulmonary Arterial Hypertension (PAH) Medicine Market Size Growth Rate by Application 2020-2026 (K Units)
Table 8. Global Pulmonary Arterial Hypertension (PAH) Medicine Market Size by Region (K Units) & (US$ Million): 2020 VS 2026
Table 9. Global Pulmonary Arterial Hypertension (PAH) Medicine Sales by Regions 2015-2020 (K Units)
Table 10. Global Pulmonary Arterial Hypertension (PAH) Medicine Sales Market Share by Regions (2015-2020)
Table 11. Global Pulmonary Arterial Hypertension (PAH) Medicine Revenue by Regions 2015-2020 (US$ Million)
Table 12. Global Pulmonary Arterial Hypertension (PAH) Medicine Sales Forecast by Region (2021-2026) (K Units)
Table 13. Global Pulmonary Arterial Hypertension (PAH) Medicine Sales by Manufacturers (2015-2020) (K Units)
Table 14. Global Pulmonary Arterial Hypertension (PAH) Medicine Sales Share by Manufacturers (2015-2020)
Table 15. Global Pulmonary Arterial Hypertension (PAH) Medicine Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 16. Global Pulmonary Arterial Hypertension (PAH) Medicine by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Pulmonary Arterial Hypertension (PAH) Medicine as of 2019)
Table 17. Pulmonary Arterial Hypertension (PAH) Medicine Revenue by Manufacturers (2015-2020) (US$ Million)
Table 18. Pulmonary Arterial Hypertension (PAH) Medicine Revenue Share by Manufacturers (2015-2020)
Table 19. Key Manufacturers Pulmonary Arterial Hypertension (PAH) Medicine Price (2015-2020) (USD/Units)
Table 20. Pulmonary Arterial Hypertension (PAH) Medicine Manufacturers Manufacturing Base Distribution and Headquarters
Table 21. Manufacturers Pulmonary Arterial Hypertension (PAH) Medicine Product Type
Table 22. Date of International Manufacturers Enter into Pulmonary Arterial Hypertension (PAH) Medicine Market
Table 23. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 24. Global Pulmonary Arterial Hypertension (PAH) Medicine Sales by Type (2015-2020) (K Units)
Table 25. Global Pulmonary Arterial Hypertension (PAH) Medicine Sales Share by Type (2015-2020)
Table 26. Global Pulmonary Arterial Hypertension (PAH) Medicine Revenue by Type (2015-2020) (US$ Million)
Table 27. Global Pulmonary Arterial Hypertension (PAH) Medicine Revenue Share by Type (2015-2020)
Table 28. Pulmonary Arterial Hypertension (PAH) Medicine Average Selling Price (ASP) by Type 2015-2020 (USD/Units)
Table 29. Global Pulmonary Arterial Hypertension (PAH) Medicine Sales Share by Type (2021-2026)
Table 30. Global Pulmonary Arterial Hypertension (PAH) Medicine Sales by Application (2015-2020) (K Units)
Table 31. Global Pulmonary Arterial Hypertension (PAH) Medicine Sales Share by Application (2015-2020)
Table 32. Global Pulmonary Arterial Hypertension (PAH) Medicine Sales Share by Application (2021-2026)
Table 33. Global Pulmonary Arterial Hypertension (PAH) Medicine Sales Market Share Forecast by Application (2021-2026)
Table 34. Global Pulmonary Arterial Hypertension (PAH) Medicine Revenue by Application (2015-2020) (US$ Million)
Table 35. Global Pulmonary Arterial Hypertension (PAH) Medicine Revenue Market Share Forecast by Application (2021-2026)
Table 36. China Pulmonary Arterial Hypertension (PAH) Medicine Sales (K Units) of Key Companies (2015-2020)
Table 37. China Pulmonary Arterial Hypertension (PAH) Medicine Sales Share by Company (2015-2020)
Table 38. China Pulmonary Arterial Hypertension (PAH) Medicine Revenue (US$ Million) by Company (2015-2020)
Table 39. China Pulmonary Arterial Hypertension (PAH) Medicine Sales (K Units) by Type (2015-2020)
Table 40. China Pulmonary Arterial Hypertension (PAH) Medicine Sales Share by Type (2015-2020)
Table 41. China Pulmonary Arterial Hypertension (PAH) Medicine Revenue (US$ Million) Market Share by Type (2015-2020)
Table 42. China Pulmonary Arterial Hypertension (PAH) Medicine Price (K Units) by Type (2015-2020)
Table 43. China Pulmonary Arterial Hypertension (PAH) Medicine Sales (K Units) by Type (2021-2026)
Table 44. China Pulmonary Arterial Hypertension (PAH) Medicine Sales Share by Type (2021-2026)
Table 45. China Pulmonary Arterial Hypertension (PAH) Medicine Revenue (US$ Million) Market Share by Type (2021-2026)
Table 46. China Pulmonary Arterial Hypertension (PAH) Medicine Revenue Share by Type (2021-2026)
Table 47. China Pulmonary Arterial Hypertension (PAH) Medicine Price (K Units) by Type (2021-2026)
Table 48. China Pulmonary Arterial Hypertension (PAH) Medicine Sales (K Units) by Application (2015-2020)
Table 49. China Pulmonary Arterial Hypertension (PAH) Medicine Sales Share by Application (2015-2020)
Table 50. China Pulmonary Arterial Hypertension (PAH) Medicine Revenue (US$ Million) Market Share by Application (2015-2020)
Table 51. China Pulmonary Arterial Hypertension (PAH) Medicine Sales (K Units) by Application (2021-2026)
Table 52. China Pulmonary Arterial Hypertension (PAH) Medicine Sales Share by Application (2021-2026)
Table 53. China Pulmonary Arterial Hypertension (PAH) Medicine Revenue (US$ Million) Market Share by Application (2021-2026)
Table 54. China Pulmonary Arterial Hypertension (PAH) Medicine Revenue Share by Application (2021-2026)
Table 55. North America Pulmonary Arterial Hypertension (PAH) Medicine Sales by Country (2015-2020) (K Units)
Table 56. North America Pulmonary Arterial Hypertension (PAH) Medicine Sales Market Share by Country (2015-2020)
Table 57. North America Pulmonary Arterial Hypertension (PAH) Medicine Revenue by Country (2015-2020) (US$ Million)
Table 58. North America Pulmonary Arterial Hypertension (PAH) Medicine Revenue Market Share by Country (2015-2020)
Table 59. Europe Pulmonary Arterial Hypertension (PAH) Medicine Sales by Country (2015-2020) (K Units)
Table 60. Europe Pulmonary Arterial Hypertension (PAH) Medicine Sales Market Share by Country (2015-2020)
Table 61. Europe Pulmonary Arterial Hypertension (PAH) Medicine Revenue by Country (2015-2020) (US$ Million)
Table 62. Europe Pulmonary Arterial Hypertension (PAH) Medicine Revenue Market Share by Country (2015-2020)
Table 63. Asia Pacific Pulmonary Arterial Hypertension (PAH) Medicine Sales by Region (2015-2020) (K Units)
Table 64. Asia Pacific Pulmonary Arterial Hypertension (PAH) Medicine Sales Market Share by Region (2015-2020)
Table 65. Asia Pacific Pulmonary Arterial Hypertension (PAH) Medicine Revenue by Region (2015-2020) (US$ Million)
Table 66. Asia Pacific Pulmonary Arterial Hypertension (PAH) Medicine Revenue Market Share by Region (2015-2020)
Table 67. Latin America Pulmonary Arterial Hypertension (PAH) Medicine Sales by Country (2015-2020) (K Units)
Table 68. Latin America Pulmonary Arterial Hypertension (PAH) Medicine Sales Market Share by Country (2015-2020)
Table 69. Latin Americaa Pulmonary Arterial Hypertension (PAH) Medicine Revenue by Country (2015-2020) (US$ Million)
Table 70. Latin America Pulmonary Arterial Hypertension (PAH) Medicine Revenue Market Share by Country (2015-2020)
Table 71. Middle East and Africa Pulmonary Arterial Hypertension (PAH) Medicine Sales by Country (2015-2020) (K Units)
Table 72. Middle East and Africa Pulmonary Arterial Hypertension (PAH) Medicine Sales Market Share by Country (2015-2020)
Table 73. Middle East and Africa Pulmonary Arterial Hypertension (PAH) Medicine Revenue by Country (2015-2020) (US$ Million)
Table 74. Middle East and Africa Pulmonary Arterial Hypertension (PAH) Medicine Revenue Market Share by Country (2015-2020)
Table 75. Pfizer Corporation Information
Table 76. Pfizer Description and Business Overview
Table 77. Pfizer Pulmonary Arterial Hypertension (PAH) Medicine Sales (K Units), Revenue (US$ Million), Price (USD/Units) and Gross Margin (2015-2020)
Table 78. Pfizer Pulmonary Arterial Hypertension (PAH) Medicine Product
Table 79. Pfizer Recent Development
Table 80. Gilead Sciences Corporation Information
Table 81. Gilead Sciences Description and Business Overview
Table 82. Gilead Sciences Pulmonary Arterial Hypertension (PAH) Medicine Sales (K Units), Revenue (US$ Million), Price (USD/Units) and Gross Margin (2015-2020)
Table 83. Gilead Sciences Product
Table 84. Gilead Sciences Recent Development
Table 85. Eli Lilly Corporation Information
Table 86. Eli Lilly Description and Business Overview
Table 87. Eli Lilly Pulmonary Arterial Hypertension (PAH) Medicine Sales (K Units), Revenue (US$ Million), Price (USD/Units) and Gross Margin (2015-2020)
Table 88. Eli Lilly Product
Table 89. Eli Lilly Recent Development
Table 90. Actelion Pharmaceuticals Corporation Information
Table 91. Actelion Pharmaceuticals Description and Business Overview
Table 92. Actelion Pharmaceuticals Pulmonary Arterial Hypertension (PAH) Medicine Sales (K Units), Revenue (US$ Million), Price (USD/Units) and Gross Margin (2015-2020)
Table 93. Actelion Pharmaceuticals Product
Table 94. Actelion Pharmaceuticals Recent Development
Table 95. United Therapeutics Corporation Corporation Information
Table 96. United Therapeutics Corporation Description and Business Overview
Table 97. United Therapeutics Corporation Pulmonary Arterial Hypertension (PAH) Medicine Sales (K Units), Revenue (US$ Million), Price (USD/Units) and Gross Margin (2015-2020)
Table 98. United Therapeutics Corporation Product
Table 99. United Therapeutics Corporation Recent Development
Table 100. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 101. Key Challenges
Table 102. Market Risks
Table 103. Main Points Interviewed from Key Pulmonary Arterial Hypertension (PAH) Medicine Players
Table 104. Pulmonary Arterial Hypertension (PAH) Medicine Customers List
Table 105. Pulmonary Arterial Hypertension (PAH) Medicine Distributors List
Table 106. Research Programs/Design for This Report
Table 107. Key Data Information from Secondary Sources
Table 108. Key Data Information from Primary Sources
List of Figures
Figure 1. Pulmonary Arterial Hypertension (PAH) Medicine Product Picture
Figure 2. Global Pulmonary Arterial Hypertension (PAH) Medicine Sales Market Share by Type in 2020 & 2026
Figure 3. Calcium Channel Blockers Product Picture
Figure 4. Novel Targeted Drugs Product Picture
Figure 5. Other Product Picture
Figure 6. Global Pulmonary Arterial Hypertension (PAH) Medicine Sales Market Share by Application in 2020 & 2026
Figure 7. Secondary Pulmonary Hypertension (SPH)
Figure 8. Primary Pulmonary Hypertension (PPH)
Figure 9. Pulmonary Arterial Hypertension (PAH) Medicine Report Years Considered
Figure 10. Global Pulmonary Arterial Hypertension (PAH) Medicine Market Size 2015-2026 (US$ Million)
Figure 11. Global Pulmonary Arterial Hypertension (PAH) Medicine Sales 2015-2026 (K Units)
Figure 12. Global Pulmonary Arterial Hypertension (PAH) Medicine Market Size Market Share by Region: 2020 Versus 2026
Figure 13. Global Pulmonary Arterial Hypertension (PAH) Medicine Sales Market Share by Region (2015-2020)
Figure 14. Global Pulmonary Arterial Hypertension (PAH) Medicine Sales Market Share by Region in 2019
Figure 15. Global Pulmonary Arterial Hypertension (PAH) Medicine Revenue Market Share by Region (2015-2020)
Figure 16. Global Pulmonary Arterial Hypertension (PAH) Medicine Revenue Market Share by Region in 2019
Figure 17. Global Pulmonary Arterial Hypertension (PAH) Medicine Sales Share by Manufacturer in 2019
Figure 18. The Top 10 and 5 Players Market Share by Pulmonary Arterial Hypertension (PAH) Medicine Revenue in 2019
Figure 19. Pulmonary Arterial Hypertension (PAH) Medicine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 20. Global Pulmonary Arterial Hypertension (PAH) Medicine Sales Market Share by Type (2015-2020)
Figure 21. Global Pulmonary Arterial Hypertension (PAH) Medicine Sales Market Share by Type in 2019
Figure 22. Global Pulmonary Arterial Hypertension (PAH) Medicine Revenue Market Share by Type (2015-2020)
Figure 23. Global Pulmonary Arterial Hypertension (PAH) Medicine Revenue Market Share by Type in 2019
Figure 24. Global Pulmonary Arterial Hypertension (PAH) Medicine Market Share by Price Range (2015-2020)
Figure 25. Global Pulmonary Arterial Hypertension (PAH) Medicine Sales Market Share by Application (2015-2020)
Figure 26. Global Pulmonary Arterial Hypertension (PAH) Medicine Sales Market Share by Application in 2019
Figure 27. Global Pulmonary Arterial Hypertension (PAH) Medicine Revenue Market Share by Application (2015-2020)
Figure 28. Global Pulmonary Arterial Hypertension (PAH) Medicine Revenue Market Share by Application in 2019
Figure 29. China Pulmonary Arterial Hypertension (PAH) Medicine Sales Growth Rate 2015-2026 (K Units)
Figure 30. China Pulmonary Arterial Hypertension (PAH) Medicine Revenue Growth Rate 2015-2026 (US$ Million)
Figure 31. China Pulmonary Arterial Hypertension (PAH) Medicine Market Share in Global Market 2015-2026
Figure 32. China 5 and 10 Largest Pulmonary Arterial Hypertension (PAH) Medicine Players Market Share by Revenue in Pulmonary Arterial Hypertension (PAH) Medicine in 2019
Figure 33. China Pulmonary Arterial Hypertension (PAH) Medicine Revenue Share by Type (2015-2020)
Figure 34. China Pulmonary Arterial Hypertension (PAH) Medicine Revenue Growth Rate by Type in 2015 & 2019
Figure 35. China Pulmonary Arterial Hypertension (PAH) Medicine Revenue Share by Application (2015-2020)
Figure 36. China Pulmonary Arterial Hypertension (PAH) Medicine Revenue Growth Rate by Application in 2015 & 2019
Figure 37. North America Pulmonary Arterial Hypertension (PAH) Medicine Sales Growth Rate 2015-2020 (K Units)
Figure 38. North America Pulmonary Arterial Hypertension (PAH) Medicine Revenue Growth Rate 2015-2020 (US$ Million)
Figure 39. North America Pulmonary Arterial Hypertension (PAH) Medicine Sales Market Share by Country in 2019
Figure 40. North America Pulmonary Arterial Hypertension (PAH) Medicine Revenue Market Share by Country in 2019
Figure 41. U.S. Pulmonary Arterial Hypertension (PAH) Medicine Sales Growth Rate (2015-2020) (K Units)
Figure 42. U.S. Pulmonary Arterial Hypertension (PAH) Medicine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 43. Canada Pulmonary Arterial Hypertension (PAH) Medicine Sales Growth Rate (2015-2020) (K Units)
Figure 44. Canada Pulmonary Arterial Hypertension (PAH) Medicine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 45. Europe Pulmonary Arterial Hypertension (PAH) Medicine Sales Growth Rate 2015-2020 (K Units)
Figure 46. Europe Pulmonary Arterial Hypertension (PAH) Medicine Revenue Growth Rate 2015-2020 (US$ Million)
Figure 47. Europe Pulmonary Arterial Hypertension (PAH) Medicine Sales Market Share by Country in 2019
Figure 48. Europe Pulmonary Arterial Hypertension (PAH) Medicine Revenue Market Share by Country in 2019
Figure 49. Germany Pulmonary Arterial Hypertension (PAH) Medicine Sales Growth Rate (2015-2020) (K Units)
Figure 50. Germany Pulmonary Arterial Hypertension (PAH) Medicine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 51. France Pulmonary Arterial Hypertension (PAH) Medicine Sales Growth Rate (2015-2020) (K Units)
Figure 52. France Pulmonary Arterial Hypertension (PAH) Medicine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 53. U.K. Pulmonary Arterial Hypertension (PAH) Medicine Sales Growth Rate (2015-2020) (K Units)
Figure 54. U.K. Pulmonary Arterial Hypertension (PAH) Medicine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 55. Italy Pulmonary Arterial Hypertension (PAH) Medicine Sales Growth Rate (2015-2020) (K Units)
Figure 56. Italy Pulmonary Arterial Hypertension (PAH) Medicine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 57. Russia Pulmonary Arterial Hypertension (PAH) Medicine Sales Growth Rate (2015-2020) (K Units)
Figure 58. Russia Pulmonary Arterial Hypertension (PAH) Medicine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 59. Asia Pacific Pulmonary Arterial Hypertension (PAH) Medicine Sales Growth Rate 2015-2020 (K Units)
Figure 60. Asia Pacific Pulmonary Arterial Hypertension (PAH) Medicine Revenue Growth Rate 2015-2020 (US$ Million)
Figure 61. Asia Pacific Pulmonary Arterial Hypertension (PAH) Medicine Sales Market Share by Region in 2019
Figure 62. Asia Pacific Pulmonary Arterial Hypertension (PAH) Medicine Revenue Market Share by Region in 2019
Figure 63. China Pulmonary Arterial Hypertension (PAH) Medicine Sales Growth Rate (2015-2020) (K Units)
Figure 64. China Pulmonary Arterial Hypertension (PAH) Medicine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 65. Japan Pulmonary Arterial Hypertension (PAH) Medicine Sales Growth Rate (2015-2020) (K Units)
Figure 66. Japan Pulmonary Arterial Hypertension (PAH) Medicine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 67. South Korea Pulmonary Arterial Hypertension (PAH) Medicine Sales Growth Rate (2015-2020) (K Units)
Figure 68. South Korea Pulmonary Arterial Hypertension (PAH) Medicine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 69. India Pulmonary Arterial Hypertension (PAH) Medicine Sales Growth Rate (2015-2020) (K Units)
Figure 70. India Pulmonary Arterial Hypertension (PAH) Medicine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 71. Australia Pulmonary Arterial Hypertension (PAH) Medicine Sales Growth Rate (2015-2020) (K Units)
Figure 72. Australia Pulmonary Arterial Hypertension (PAH) Medicine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 73. Taiwan Pulmonary Arterial Hypertension (PAH) Medicine Sales Growth Rate (2015-2020) (K Units)
Figure 74. Taiwan Pulmonary Arterial Hypertension (PAH) Medicine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 75. Indonesia Pulmonary Arterial Hypertension (PAH) Medicine Sales Growth Rate (2015-2020) (K Units)
Figure 76. Indonesia Pulmonary Arterial Hypertension (PAH) Medicine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 77. Thailand Pulmonary Arterial Hypertension (PAH) Medicine Sales Growth Rate (2015-2020) (K Units)
Figure 78. Thailand Pulmonary Arterial Hypertension (PAH) Medicine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 79. Malaysia Pulmonary Arterial Hypertension (PAH) Medicine Sales Growth Rate (2015-2020) (K Units)
Figure 80. Malaysia Pulmonary Arterial Hypertension (PAH) Medicine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 81. Philippines Pulmonary Arterial Hypertension (PAH) Medicine Sales Growth Rate (2015-2020) (K Units)
Figure 82. Philippines Pulmonary Arterial Hypertension (PAH) Medicine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 83. Vietnam Pulmonary Arterial Hypertension (PAH) Medicine Sales Growth Rate (2015-2020) (K Units)
Figure 84. Vietnam Pulmonary Arterial Hypertension (PAH) Medicine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 85. Latin America Pulmonary Arterial Hypertension (PAH) Medicine Sales Growth Rate 2015-2020 (K Units)
Figure 86. Latin America Pulmonary Arterial Hypertension (PAH) Medicine Revenue Growth Rate 2015-2020 (US$ Million)
Figure 87. Latin America Pul

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Pulmonary Arterial Hypertension (Pah) Medicine Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 04-Jan-2024        Price: US 3380 Onwards        Pages: 103

Market Overview of Global Pulmonary Arterial Hypertension (Pah) Medicine market: According to our latest research, the global Pulmonary Arterial Hypertension (Pah) Medicine market looks promising in the next 5 years. As of 2022, the global Pulmonary Arterial Hypertension (Pah) Medicine market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to ......

Global Nifedipine Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 04-Jan-2024        Price: US 3380 Onwards        Pages: 102

Market Overview of Global Nifedipine market: According to our latest research, the global Nifedipine market looks promising in the next 5 years. As of 2022, the global Nifedipine market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of the global Nifedipine market, with a systematical de......

Global Amlodipine Besylate Market Research Report 2024

Published: 04-Jan-2024        Price: US 2900 Onwards        Pages: 115

The Amlodipine Besylate market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Amlodipine Besylate market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profil......

Pulmonary Arterial Hypertension (PAH) Drugs - Global Market Insights and Sales Trends 2024

Published: 25-Dec-2023        Price: US 3350 Onwards        Pages: 112

The global Pulmonary Arterial Hypertension (PAH) Drugs market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Pulmonary Arterial Hypertension (PAH) Drugs in various end use industries. The expanding demands from the Hospitals, Clinics and Other,, are propelling Pulmonary Arterial Hypertension (PAH) Drugs market. Inhalation, one of the segments analysed in this report, is projected to record % ......

Captopril API - Global Market Insights and Sales Trends 2024

Published: 25-Dec-2023        Price: US 3350 Onwards        Pages: 100

The global Captopril API market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Captopril API in various end use industries. The expanding demands from the Captopril Tablet, Compound Captopril Tablet and Captopril Injection,, are propelling Captopril API market. 98% Captopril API, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the......

Telmisartan - Global Market Insights and Sales Trends 2024

Published: 21-Dec-2023        Price: US 3350 Onwards        Pages: 107

The global Telmisartan market size is expected to reach US$ 3631.3 million by 2029, growing at a CAGR of 3.4% from 2023 to 2029. The market is mainly driven by the significant applications of Telmisartan in various end use industries. The expanding demands from the Hospital, Clinic and Others,, are propelling Telmisartan market. Injection, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Freeze-Dried......

Global Ambrisentan Professional Survey Report 2023, Forecast to 2028

Published: 20-Dec-2023        Price: US 3280 Onwards        Pages: 106

Ambrisentan is a drug indicated for use in the treatment of pulmonary hypertension. The peptide endothelin constricts muscles in blood vessels, increasing blood pressure. Ambrisentan, which relaxes those muscles, is an endothelin receptor antagonist, and is selective for the type A endothelin receptor. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million US......

Global Ambrisentan Market Research Report 2023, Forecast to 2028

Published: 20-Dec-2023        Price: US 2680 Onwards        Pages: 132

Ambrisentan is a drug indicated for use in the treatment of pulmonary hypertension. The peptide endothelin constricts muscles in blood vessels, increasing blood pressure. Ambrisentan, which relaxes those muscles, is an endothelin receptor antagonist, and is selective for the type A endothelin receptor. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million US......

Global Amlodipine Besylate Professional Survey Report 2023, Forecast to 2028

Published: 20-Dec-2023        Price: US 3280 Onwards        Pages: 133

Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while taking advantage of emerging opportunities. Technological advancements, new product launches, and market capital flows are compared across scenarios to demonstrate their impact over the forecast period. D......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs